Table 1. Patient characteristics by prescription of ACEI/ARBs.
| Baseline | Yes (n (%)) | No (n (%)) | |||
|---|---|---|---|---|---|
| Age (years) | 18 to 42 | 16 616 | (10.4%) | 94 265 | (22.9%) |
| 43 to 53 | 39 541 | (24.8%) | 77 224 | (18.8%) | |
| 54 to 62 | 36 325 | (22.8%) | 77 985 | (19.0%) | |
| 63 to 71 | 30 667 | (19.2%) | 75 141 | (18.3%) | |
| ≥ 72 | 36 240 | (22.7%) | 86 582 | (21.1%) | |
| Sex | Female | 62 652 | (39.3%) | 236 296 | (57.5%) |
| Chronic Kidney Disease Stage | ≤ Stage 2 | 88 826 | (55.7%) | 146 825 | (35.7%) |
| Stage 3a | 10 535 | (6.6%) | 15 489 | (3.8%) | |
| Stage 3b | 2728 | (1.7%) | 3127 | (0.8%) | |
| Stage 4 | 457 | (0.3%) | 551 | (0.1%) | |
| Missing | 56 843 | (35.7%) | 245 205 | (59.6%) | |
| Ethnicity | White | 63 791 | (40.0%) | 153 747 | (37.4%) |
| South Asian | 3072 | (1.9%) | 4734 | (1.2%) | |
| Black | 1065 | (0.7%) | 3905 | (0.9%) | |
| Mixed | 237 | (0.1%) | 681 | (0.2%) | |
| Other | 814 | (0.5%) | 1623 | (0.4%) | |
| Missing | 90 410 | (56.7%) | 246 507 | (59.9%) | |
| Comorbidities: | |||||
| Diabetes Mellitus | Yes | 44 727 | (28.1%) | 38 714 | (9.4%) |
| Ischaemic heart disease | Yes | 42 214 | (26.5%) | 76 013 | (18.5%) |
| Arrhythmia | Yes | 17 494 | (11.0%) | 39 094 | (9.5%) |
| Cardiac failure | Yes | 18 647 | (11.7%) | 13 074 | (3.2%) |
| Hypertension | Yes | 124 340 | (78.0%) | 240 135 | (58.4%) |
| Other antihypertensives: | |||||
| Beta-blocker | Yes | 14 666 | (9.2%) | 205 156 | (49.9%) |
| Calcium channel blocker | Yes | 3501 | (2.2%) | 91 912 | (22.4%) |
| Diuretic | Yes | 21 950 | (13.8%) | 129 582 | (31.5%) |
Abbreviations: ACEI/ARBs, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Diuretic: Thiazide diuretics, loop diuretics, or potassium sparing diuretics.